This compound is primarily utilized in the synthesis of pharmaceutical agents, particularly those targeting inflammatory and autoimmune conditions. It serves as a key intermediate in the production of drugs like apremilast, which is used to treat psoriasis and psoriatic arthritis. Its structure allows for effective modulation of phosphodiesterase-4 (PDE4) inhibitors, contributing to the reduction of inflammation and immune response. Additionally, it is employed in research and development for exploring new therapeutic options in immunology and rheumatology.